Femasys, a biomedical company specializing in women’s health, announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for FemChec, adiagnostic tool for checking the fallopian tubes. This new solution is designed for controlled delivery of contrast media, allowing for clearer confirmation of tubal status during ultrasound evaluations. Kathy Lee-Sepsick, founder and CEO of Femasys,…
CooperSurgical has introduced a new single-hand inserter for its Paragard intrauterine copper contraceptive (IUD). Recently approved by the U.S. Food and Drug Administration (FDA), this new inserter is designed to simplify the insertion process, making Paragard more accessible for healthcare providers and patients. Paragard has been a trusted option for over 30 years, offering more than 99% efficacy in preventing pregnancy for…
HANX, the UK-based sexual wellness and intimate care brand, has announced a significant expansion of its digital pharmacy services with the introduction of GLP-1 medications, marking its evolution into the broader femtech category. The new weight management offering is designed to support women struggling with conditions like Polycystic Ovary Syndrome (PCOS), endometriosis, and menopause. The GLP-1 medications, Mounjaro (tirzepatide) and Wegovy (semaglutide),…
Tennis legend Maria Sharapova has joined Cofertility as their newest investor, bringing her influence and financial backing to the startup. Cofertility aims to make egg freezing more accessible and affordable by linking it with egg donation, offering women the opportunity to freeze their eggs for free when they donate half to intended parents who are unable to conceive. Sharapova, who retired from…
Aetna, a CVS Health company, is now the first major insurer in the US to include intrauterine insemination (IUI) as a covered medical benefit for all eligible plans. This new coverage will be available beginning September 1, 2024, and aims to increase access to fertility services for a broader range of individuals, regardless of sexual orientation or partner status. Previously, coverage for…
Alife Health, a fertility technology company focused on modernizing in vitro fertilization (IVF) through AI, has revealed promising findings from a study that explores the role of artificial intelligence in optimizing ovarian stimulation during IVF treatment. The study, titled “Optimizing Oocyte Yield Utilizing a Machine Learning Model for Dose and Trigger Decisions: A Multi-Center, Prospective Study,” was conducted by a team of…
Reproductive health app Clue has partnered with mental health platform Headspace to provide tailored support for women and people with cycles navigating mental health challenges linked to their menstrual health. Through this collaboration, Clue Plus members will have access to a 50% discount on a Headspace subscription, offering resources designed to help manage cycle-related stress and enhance overall well-being. This partnership addresses…
Toronto-based startup Fibra has closed its oversubscribed pre-seed funding round, raising $1.25 million USD ($1.7 million CAD). The funding will be used to accelerate the development of Fibra’s smart underwear technology designed to ease reproductive health monitoring for women. The round saw participation from Canadian and U.S.-based venture capital firms, reflecting growing investor confidence in innovations focused on women’s health. “We are…
